Gwenn Hansen
Vermogen: 3 M $ op 31-07-2026
Vermogen: 3 M $ op 31-07-2026
Gwenn M.
Hansen is Chief Scientific Officer at Nurix Therapeutics, Inc. since 2020, with employment at the company starting in 2015.
Formerly, served as Associate Professor at Baylor College of Medicine.
Education includes undergraduate studies at Gustavus Adolphus College and a doctorate from the University of Tennessee.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-08-2026 | 117.227 ( 0,11% ) | 3 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Gustavus Adolphus College
Gustavus Adolphus College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau